MARKET WIRE NEWS
  1. Home
  2. Stock
  3. LGNZZ
  4. News
LGNZZ
Quote
Short
News
Articles
Message Board

Ligand Pharmaceuticals, Inc. Contingent Value Rights (Tr Beta) (OTCMKTS : LGNZZ ) News

Ligand Pharmaceuticals, Inc. Contingent Value Rights (Tr Beta) (OTCMKTS: LGNZZ) News Releases

LGNZZ News Releases
LGNZZ : OTC
SeekingAlpha
Ligand outlines 23% CAGR royalty growth outlook through 2030 as royalty portfolio accelerates
LGNZZ : OTC
SeekingAlpha
Ligand Pharmaceuticals Incorporated (LGND) Q4 2025 Earnings Call Transcript
LGNZZ : OTC
SeekingAlpha
Ligand Pharmaceuticals Incorporated (LGND) Analyst/Investor Day Transcript
LGNZZ : OTC
SeekingAlpha
Ligand Pharmaceuticals Incorporated (LGND) Q3 2025 Earnings Call Transcript
LGNZZ : OTC
SeekingAlpha
Ligand raises 2025 revenue and EPS guidance to $225M and $7 amid royalty portfolio momentum
LGNZZ : OTC
SeekingAlpha
Ligand Pharmaceuticals Incorporated (LGND) Q2 2025 Earnings Call Transcript
LGNZZ : OTC
SeekingAlpha
Ligand Pharmaceuticals sees 22% CAGR in royalty revenue through 2029
LGNZZ : OTC
SeekingAlpha
Ligand Pharmaceuticals Incorporated (LGND) Q1 2025 Earnings Call Transcript
LGNZZ : OTC
SeekingAlpha
Bumbershoot Holdings 2024 Investor Letter
LGNZZ : OTC
SeekingAlpha
Ligand Pharmaceuticals Incorporated (LGND) Q4 2024 Earnings Call Transcript

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.